SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-15-404971
Filing Date
2015-12-16
Accepted
2015-12-16 17:00:06
Documents
9
Period of Report
2015-12-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d86590d8k.htm 8-K 28514
2 EX-1.1 d86590dex11.htm EX-1.1 193679
3 EX-1.2 d86590dex12.htm EX-1.2 193023
4 EX-3.1 d86590dex31.htm EX-3.1 81566
5 EX-4.1 d86590dex41.htm EX-4.1 6158
6 EX-5.1 d86590dex51.htm EX-5.1 10709
7 EX-99.1 d86590dex991.htm EX-99.1 7888
8 GRAPHIC g86590g53n55.jpg GRAPHIC 2435
9 GRAPHIC g86590g99k88.jpg GRAPHIC 2383
  Complete submission text file 0001193125-15-404971.txt   529903
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51531 | Film No.: 151291544
SIC: 2834 Pharmaceutical Preparations